Dr Emmanuel Chukwuwiken OKOH
Research Clinician
Medical Research Council The Gambia Unit@ London School of Hygiene and tropical medicine(MRCG@LSHTM)
Atlantic Boulevard Fajara
Banjul
Gambia
Dr Emmanuel Chukwuwiken Okoh graduated in Medicine and Surgery at College of Medicine, Ambrose Alli University Nigeria in 2008, obtained a Master of Public Health (MPH) at University of Benin, Nigeria in 2016, and a specialist qualification in Public Health from the West African College of Physicians, Nigeria in 2017. He worked as a clinician at the Irrua Specialist Teaching Hospital, Nigeria. He subsequently worked as a field epidemiologist with WHO Edo State (Nigeria) for 2 years where he played an active role in the control of Lassa fever epidemics, surveillance of acute flaccid paralysis, yellow fever, and measles. In 2020, he joined MRC Unit The Gambia at London School of Hygiene and Tropical Medicine as a clinical trial research clinician and performed both managerial and clinical duties in the “ETVAX vaccine efficacy and safety trial” and in the comparative study of “Haem iron versus ferrous iron salts in treating iron deficiency anemia in Gambian children”. In 2020, during the Covid-19 outbreak in the Gambia, he worked with the medical team of MRC Unit The Gambia at London School of Hygiene and Tropical Medicine as the deputy physician co-ordinator in the management of Covid-19 cases and in setting up the virtual ward clinic for the management of mild and moderate Covid-19 cases.
Affiliations
MRC Unit The Gambia at LSHTM
Teaching
I am an external examiner, in Community Health, for part IV MBCHB final year medical students at the University of The Gambia.
Research
My research interests cut across infectious disease epidemiology, environmental epidemiology, vaccines/immunity and public health nutrition.
Recent clinical trials I have undertaken include:
"Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children aged 6-12 months: a randomized controlled trial"
"An individually randomized, double-blind, placebo-controlled phase 2b trial (OEV-128) examining the efficacy of Oral inactivated ETVAX vaccine to prevent Enterotoxigenic E. coli- associated diarrhea among Gambian children ages 6-18months"
Recent clinical trials I have undertaken include:
"Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children aged 6-12 months: a randomized controlled trial"
"An individually randomized, double-blind, placebo-controlled phase 2b trial (OEV-128) examining the efficacy of Oral inactivated ETVAX vaccine to prevent Enterotoxigenic E. coli- associated diarrhea among Gambian children ages 6-18months"
Selected Publications
Intense and Mild First Epidemic Wave of Coronavirus Disease, The Gambia.
2021
Emerging infectious diseases
Clinical Presentation and Outcome of Ribavirin Treated RT-PCR Confirmed Lassa Fever Patients in ISTH Irrua: A Pilot Study
2016
Research in Health Science
Housing Factors and Transmission of Lassa Fever in a Rural Area of South-south Nigeria - TI Journals
2014
General Health and Medical Sciences
Market sanitation: A case study of Oregbeni market Benin-city Edo State, Nigeria
2013
International Journal of Basic, Applied and Innovative Research
Awareness, Ownership and Utilization of Insecticide Treated Nets in Abavo Community of Delta State
2013
Nigerian Journal of Medicine